» Articles » PMID: 23634178

The Role of Surgical Resection in Patients with Brain Metastases

Overview
Specialty Oncology
Date 2013 May 2
PMID 23634178
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Brain metastasis is a devastating complication of systemic malignancy that affects a considerable number of cancer patients. The appearance of brain metastases is often considered to be a sign of poor prognosis; in patients with brain metastases poor survival time has been reported in the literature. Therefore, treatment of these brain lesions in cancer patients is important for quality of life, providing local tumour control, preventing death from neurological causes, and improving survival, although potentially only in a minority of patients. Surgical resection of brain metastases has been the cornerstone treatment in select patients. Careful patient selection, the use of appropriate surgical techniques, and surgical adjuncts are the major determinants of favourable outcome in patients undergoing resection of brain metastases. In this review, we explain the role of surgical resection in the treatment of patients with brain metastases with consideration of patient selection, surgical techniques and the use of intraoperative adjuncts.

Citing Articles

Cancer brain metastasis: molecular mechanisms and therapeutic strategies.

Lu Y, Huang Y, Zhu C, Li Z, Zhang B, Sheng H Mol Biomed. 2025; 6(1):12.

PMID: 39998776 PMC: 11861501. DOI: 10.1186/s43556-025-00251-0.


The multidisciplinary management of HER2-positive breast cancer brain metastases: from new biological insights to future therapeutic options.

von Arx C, Calderaio C, Calabrese A, Marciano B, Martinelli C, Lauro V Front Oncol. 2025; 14:1447508.

PMID: 39749036 PMC: 11693720. DOI: 10.3389/fonc.2024.1447508.


A prospective study on the usefulness of high-resolution intraoperative infrared thermography in intracranial tumors.

Menezes D, de Lima L, Mansilla R, Conci A, Rueda F, Velarde L Front Surg. 2024; 11:1386722.

PMID: 38933651 PMC: 11199714. DOI: 10.3389/fsurg.2024.1386722.


Defining the role of surgery for patients with multiple brain metastases.

Ersoy T, Brainman D, Coras R, Berger B, Weissinger F, Grote A J Neurooncol. 2024; 169(2):317-328.

PMID: 38916848 PMC: 11341766. DOI: 10.1007/s11060-024-04739-7.


Radiomics-based prediction of local control in patients with brain metastases following postoperative stereotactic radiotherapy.

Buchner J, Kofler F, Mayinger M, Christ S, Brunner T, Wittig A Neuro Oncol. 2024; 26(9):1638-1650.

PMID: 38813990 PMC: 11376458. DOI: 10.1093/neuonc/noae098.


References
1.
Andrews D, Scott C, Sperduto P, Flanders A, Gaspar L, Schell M . Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet. 2004; 363(9422):1665-72. DOI: 10.1016/S0140-6736(04)16250-8. View

2.
Senft C, Ulrich C, Seifert V, Gasser T . Intraoperative magnetic resonance imaging in the surgical treatment of cerebral metastases. J Surg Oncol. 2010; 101(5):436-41. DOI: 10.1002/jso.21508. View

3.
Mintz A, Kestle J, Rathbone M, Gaspar L, Hugenholtz H, Fisher B . A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis. Cancer. 1996; 78(7):1470-6. DOI: 10.1002/(sici)1097-0142(19961001)78:7<1470::aid-cncr14>3.0.co;2-x. View

4.
Brega K, Robinson W, Winston K, Wittenberg W . Surgical treatment of brain metastases in malignant melanoma. Cancer. 1990; 66(10):2105-10. DOI: 10.1002/1097-0142(19901115)66:10<2105::aid-cncr2820661011>3.0.co;2-i. View

5.
Horton J, BAXTER D, OLSON K . The management of metastases to the brain by irradiation and corticosteroids. Am J Roentgenol Radium Ther Nucl Med. 1971; 111(2):334-6. DOI: 10.2214/ajr.111.2.334. View